内分泌機能検査の日本市場2019-2023

【英語タイトル】Japan Endocrine Function Testing Market Shares and Segment Forecasts 2019-2023

Venture Planning Groupが出版した調査資料(VPG906178)・商品コード:VPG906178
・発行会社(調査会社):Venture Planning Group
・発行日:2019年4月
・ページ数:269
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:日本
・産業分野:医療
◆販売価格オプション(消費税別)
Local PDFUSD2,750 ⇒換算¥297,000見積依頼/購入/質問フォーム
Global PDFUSD5,900 ⇒換算¥637,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

This new 269-page report from LeadingMarketResearch.com provides a comprehensive analysis in the Japanese endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab and TSH.

During the next five years, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

This report is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts; compares features of leading analyzers; and profiles key competitors

Contains 269 pages and 15 tables.

【レポートの目次】

http://www.LeadingMarketResearch.com/pdffiles/LOTEndocrineFunctionTestingMarketinJapan%20HospitalsCommercialLabs.pdf

http://www.vpgcorp.com/webfiles/CC/ClinicalChemistryCompanyProfiled.pdf

【掲載企業】

Competitive Assessments

- Abbott Laboratories
- Agilent Technologies
- Beckman Coulter/Danaher
- bioMerieux
- Bio-Rad
- DiaSorin
- Eiken Chemical
- Fujirebio
- Grifols
- Instrumentation Laboratory/Werfen
- Kyowa Medex
- Ortho-Clinical Diagnostics
- PerkinElmer
- Quest Diagnostics
- Roche
- Siemens Healthineers
- Sysmex
- Thermo Fisher
- Tosoh
- Wako


★調査レポート[内分泌機能検査の日本市場2019-2023] (コード:VPG906178)販売に関する免責事項を必ずご確認ください。
★調査レポート[内分泌機能検査の日本市場2019-2023]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆